Literature DB >> 24690004

Directing the immune system with chemical compounds.

Rock J Mancini1, Lalisa Stutts, Keun Ah Ryu, Janine K Tom, Aaron P Esser-Kahn.   

Abstract

Agonists of immune cell receptors direct innate and adaptive immunity. These agonists range in size and complexity from small molecules to large macromolecules. Here, agonists of a class of immune cell receptors known as the Toll-like receptors (TLRs) are highlighted focusing on the distinctive molecular moieties that pertain to receptor binding and activation. How the structure and combined chemical signals translate into a variety of immune responses remain major questions in the field. In this structure-focused review, we outline potential areas where the tools of chemical biology could help decipher the emerging molecular codes that direct immune stimulation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24690004      PMCID: PMC5674983          DOI: 10.1021/cb500079s

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  96 in total

1.  Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses.

Authors:  Seung-Yong Seong; Polly Matzinger
Journal:  Nat Rev Immunol       Date:  2004-06       Impact factor: 53.106

2.  Crystal structure of human toll-like receptor 3 (TLR3) ectodomain.

Authors:  Jungwoo Choe; Matthew S Kelker; Ian A Wilson
Journal:  Science       Date:  2005-06-16       Impact factor: 47.728

Review 3.  Innate immunity: impact on the adaptive immune response.

Authors:  R Medzhitov; C A Janeway
Journal:  Curr Opin Immunol       Date:  1997-02       Impact factor: 7.486

4.  Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex.

Authors:  K Ohashi; V Burkart; S Flohé; H Kolb
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

5.  Determination of the physiological 2:2 TLR5:flagellin activation stoichiometry revealed by the activity of a fusion receptor.

Authors:  Karolina Ivičak-Kocjan; Gabriela Panter; Mojca Benčina; Roman Jerala
Journal:  Biochem Biophys Res Commun       Date:  2013-04-25       Impact factor: 3.575

6.  Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4.

Authors:  Alexzander Asea; Michael Rehli; Edith Kabingu; Jason A Boch; Olivia Bare; Philip E Auron; Mary Ann Stevenson; Stuart K Calderwood
Journal:  J Biol Chem       Date:  2002-02-08       Impact factor: 5.157

Review 7.  TLR2 - promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity.

Authors:  Ulrich Zähringer; Buko Lindner; Seiichi Inamura; Holger Heine; Christian Alexander
Journal:  Immunobiology       Date:  2008-03-28       Impact factor: 3.144

8.  Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner.

Authors:  Mark Rutz; Jochen Metzger; Tanja Gellert; Peter Luppa; Grayson B Lipford; Hermann Wagner; Stefan Bauer
Journal:  Eur J Immunol       Date:  2004-09       Impact factor: 5.532

9.  Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant.

Authors:  Rhea N Coler; Sylvie Bertholet; Magdalini Moutaftsi; Jeff A Guderian; Hillarie Plessner Windish; Susan L Baldwin; Elsa M Laughlin; Malcolm S Duthie; Christopher B Fox; Darrick Carter; Martin Friede; Thomas S Vedvick; Steven G Reed
Journal:  PLoS One       Date:  2011-01-26       Impact factor: 3.240

10.  Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase.

Authors:  Sarah E Ewald; Alex Engel; Jiyoun Lee; Miqi Wang; Matthew Bogyo; Gregory M Barton
Journal:  J Exp Med       Date:  2011-03-14       Impact factor: 14.307

View more
  17 in total

1.  Multivalent Antigens for Promoting B and T Cell Activation.

Authors:  Nitasha R Bennett; Daniel B Zwick; Adam H Courtney; Laura L Kiessling
Journal:  ACS Chem Biol       Date:  2015-06-02       Impact factor: 5.100

2.  pH-degradable imidazoquinoline-ligated nanogels for lymph node-focused immune activation.

Authors:  Lutz Nuhn; Nane Vanparijs; Ans De Beuckelaer; Lien Lybaert; Glenn Verstraete; Kim Deswarte; Stefan Lienenklaus; Nikunj M Shukla; Alex C D Salyer; Bart N Lambrecht; Johan Grooten; Sunil A David; Stefaan De Koker; Bruno G De Geest
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-05       Impact factor: 11.205

Review 3.  Strategies for designing synthetic immune agonists.

Authors:  Tom Y-H Wu
Journal:  Immunology       Date:  2016-07-11       Impact factor: 7.397

4.  Immune Response Modulation of Conjugated Agonists with Changing Linker Length.

Authors:  Keun Ah Ryu; Katarzyna Slowinska; Troy Moore; Aaron Esser-Kahn
Journal:  ACS Chem Biol       Date:  2016-10-25       Impact factor: 5.100

5.  The efficiency of cytosolic drug delivery using pH-responsive endosomolytic polymers does not correlate with activation of the NLRP3 inflammasome.

Authors:  Jessalyn J Baljon; Aamina Dandy; Lihong Wang-Bishop; Mohamed Wehbe; Max E Jacobson; John T Wilson
Journal:  Biomater Sci       Date:  2019-04-23       Impact factor: 6.843

6.  Environmentally Triggerable Retinoic Acid-Inducible Gene I Agonists Using Synthetic Polymer Overhangs.

Authors:  Christian R Palmer; Max E Jacobson; Olga Fedorova; Anna M Pyle; John T Wilson
Journal:  Bioconjug Chem       Date:  2018-01-19       Impact factor: 4.774

7.  A Light-Controlled TLR4 Agonist and Selectable Activation of Cell Subpopulations.

Authors:  Lalisa Stutts; Aaron P Esser-Kahn
Journal:  Chembiochem       Date:  2015-06-26       Impact factor: 3.164

Review 8.  Big opportunities for small molecules in immuno-oncology.

Authors:  Jerry L Adams; James Smothers; Roopa Srinivasan; Axel Hoos
Journal:  Nat Rev Drug Discov       Date:  2015-07-31       Impact factor: 84.694

9.  Echinacea purpurea (L.) Moench treatment of monocytes promotes tonic interferon signaling, increased innate immunity gene expression and DNA repeat hypermethylated silencing of endogenous retroviral sequences.

Authors:  Ken Declerck; Claudina Perez Novo; Lisa Grielens; Guy Van Camp; Andreas Suter; Wim Vanden Berghe
Journal:  BMC Complement Med Ther       Date:  2021-05-12

10.  Squaric Ester-Based, pH-Degradable Nanogels: Modular Nanocarriers for Safe, Systemic Administration of Toll-like Receptor 7/8 Agonistic Immune Modulators.

Authors:  Anne Huppertsberg; Leonard Kaps; Zifu Zhong; Sascha Schmitt; Judith Stickdorn; Kim Deswarte; Francis Combes; Christian Czysch; Jana De Vrieze; Sabah Kasmi; Niklas Choteschovsky; Adrian Klefenz; Carolina Medina-Montano; Pia Winterwerber; Chaojian Chen; Matthias Bros; Stefan Lienenklaus; Niek N Sanders; Kaloian Koynov; Detlef Schuppan; Bart N Lambrecht; Sunil A David; Bruno G De Geest; Lutz Nuhn
Journal:  J Am Chem Soc       Date:  2021-06-24       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.